PhaseBio Pharmaceuticals OverviewPhaseBio Pharmaceuticals Profit Margin
Profitability ratio analysis for PHAS.
Quarterly Profit Margin
-8067.79%
↓ 2808.22% YoY
As of Jun 2022
Annual Profit Margin (TTM)
3402.93%
↑ 422.71% YoY
Trailing 12 months ending Jun 2022
Average Profit Margin (Comparison Companies)
Profit Margin History
Profit Margin Comparison
Annual Profit Margin Growth Rate (%)